I-Med Pharma USA partners with DryEye Rescue to distribute its innovative portfolio of dry eye products in the United States

Content of the article

MONTREAL, 03 Feb. 2022 (GLOBE NEWSWIRE) — With the recent launch of its line of dry eye diagnosis, management and treatment solutions in the United States, I-MED Pharma USA has partnered with DryEye Rescue of Boca Raton, Florida , to distribute and market their unique and innovative portfolio of dry eye products. DryEye Rescue will help raise awareness of the I-MED Pharma USA brand to optometrists in the United States and work with optometry clinics to develop a plan for investment and integration of appropriate products, treatment technologies and marketing of effectively to ensure that their specialty clinics can thrive.

Advertising

Content of the article

Philipp Binder, President and COO of I-MED Pharma, said, “With our recent expansion into the US market, we are thrilled to announce our partnership with DryEye Rescue to distribute our innovative portfolio of dry eye products. to PCUs across the United States. . I-MED Pharma has dedicated the past 32 years to researching and developing eye care products to help diagnose, manage and treat dry eye disease. Our mission is to bring complete relief to dry eye and ocular surface patients worldwide and our partnership with DryEye Rescue will help us achieve our goal.

Dennis Evans, Director of Professional Relations, said, “We are thrilled to be working with I-MED Pharma USA to help them grow their brand and introduce their incredible portfolio of dry eye products to eye care professionals across the United States. We look forward to a fruitful collaboration.

Advertising

Content of the article

About I-MED Pharma
I-MED Pharma USA is a subsidiary of I-MED Pharma Inc., a privately held Canadian company, headquartered in Montreal, Quebec. As a research-based company with a vision to be the world’s leading dry eye and ocular surface disease company, I-MED Pharma provides innovative OSD solutions to the global optometry community and of ophthalmology. Over the years, I-MED Pharma has continuously invested heavily in R&D and created unique and effective products for dry eye management. A pioneer in artificial tears and eye hygiene cleansers, I-MED Pharma’s flagship product lines include I-DROP ® and I-LID ‘N LASH ® which are sold worldwide.

I-MED Pharma USA offers a full line of products for ocular surface disorders, including diagnostic tools, dry eye ointment , eye hygiene cleansers , point plugs , food supplements , therapeutic accessories as good as E>Eye IRPL® a long-lasting solution specially designed for the treatment of dry eyes due to meibomian gland dysfunction.

Advertising

Content of the article

For more information, please email [email protected] or visit us.imedpharma.com.

About DryEye Rescue
DryEye Rescue is the single source to help create the right environment to cultivate dry eye patients, ensure patient compliance, and purchase all dry eye products needed by eye care facilities.

Dry Eye Relief
1200 South Rogers Circle, Suite 16, Boca Raton, Florida 33487
(561) 468-8747
DryeyeRescuePro.com

[email protected]

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/cea79354-1766-4bba-ac09-c1fc5ab595cd

main logo

Advertising

comments

Postmedia is committed to maintaining a lively yet civil discussion forum and encourages all readers to share their views on our articles. Comments can take up to an hour to be moderated before appearing on the site. We ask that you keep your comments relevant and respectful. We have enabled email notifications. You will now receive an email if you receive a reply to your comment, if there is an update to a comment thread you follow, or if a user follows you comments. See our Community Guidelines for more information and details on how to adjust your email settings.

Comments are closed.